The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
Authors:
- Stephen E. StrausSSStephen E. Straus
- Elaine S. JaffeEJElaine S. Jaffe
- Jennifer M. PuckJPJennifer M. Puck
- Janet K. DaleJDJanet K. Dale
- Keith B. ElkonKEKeith B. Elkon
- Angela Rösen-WolffARAngela Rösen-Wolff
- Anke M. J. PetersAPAnke M. J. Peters
- Michael C. SnellerMSMichael C. Sneller
- Claire W. HallahanCHClaire W. Hallahan
- Jin WangJWJin Wang
- Roxanne E. FischerRFRoxanne E. Fischer
- Christine M. JacksonCJChristine M. Jackson
Top Cited Papers
- 1 July 2001
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 98 (1) , 194-200
Abstract
Lymphomas were studied in kindreds with autoimmune lymphoproliferative syndrome (ALPS; Canale-Smith syndrome), a disorder of lymphocyte homeostasis usually associated with germline Fas mutations. Fas (CD95/APO-1) is a cell surface receptor that initiates programmed cell death, or apoptosis, of activated lymphocytes. Lymphoma phenotype was determined by immunohistochemistry, frequency of CD3+CD4−CD8− T-cell–receptor α/β cells by flow cytometry, nucleotide sequences of the gene encoding Fas ( APT1 , TNFRSF6), and the percentage of lymphocytes undergoing apoptosis in vitro. Of 223 members of 39 families, 130 individuals possessed heterozygous germline Fas mutations. Eleven B-cell and T-cell lymphomas of diverse types developed in 10 individuals with mutations in 8 families, up to 48 years after lymphoproliferation was first documented. Their risk of non-Hodgkin and Hodgkin lymphomas, respectively, was 14 and 51 times greater than expected (each P < .001). Investigation of these 10 patients and their relatives with Fas mutations revealed that all had defective lymphocyte apoptosis and most had other features of ALPS. The tumor cells retained the heterozygous Fas mutations found in the peripheral blood and manifested defective Fas-mediated killing. These data implicate a role for Fas-mediated apoptosis in preventing B-cell and T-cell lymphomas. Inherited defects in receptor-mediated lymphocyte apoptosis represent a newly appreciated risk factor for lymphomas.Keywords
This publication has 30 references indexed in Scilit:
- Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type IICell, 1999
- MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic EnvironmentAnnual Review of Immunology, 1999
- The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosisThe Journal of Pediatrics, 1998
- FasGene Mutations in the Canale–Smith Syndrome, an Inherited Lymphoproliferative Disorder Associated with AutoimmunityNew England Journal of Medicine, 1996
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.Journal of Clinical Investigation, 1996
- Clinical, immunological, and pathological consequences of Fas-deficient conditionsThe Lancet, 1996
- Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityScience, 1995
- Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeCell, 1995
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Chronic lymphadenopathy simulating malignant lymphomaThe Journal of Pediatrics, 1967